ஃப்ரெட் ஹட்சின்சன் புற்றுநோய் ஆராய்ச்சி நிறுவனம் இல் சீட்டில் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MedCity News
Startup Ozette unveils AI approach to understanding the immune system
Ozette applies artificial intelligence to immune monitoring to gain greater insight into a cancer patient s immune system. Beyond informing treatment decisions, the technology can guide drug and diagnostic development.
Shares1
 
Cancer patients receive a check-in to see how their immune cells are working and whether the disease is responding to treatment. This immune monitoring is a routine part of cancer care and it helps guide treatment decisions. Yet current analysis methods remain limited, according to Ali Ansary, co-founder and CEO of startup Ozette.
The Seattle-based company aims to take immune monitoring further and it is using artificial intelligence to do it. The approach could accelerate analysis of the immune system, helping clinicians make better diagnostic and treatment decisions. The technology could yield insights not only for cancer care, but also infectiou ....

Greg Finak , Fred Hutch , Ali Ansary , Fred Hutchinson Cancer Research Institute In Seattle , Allen Institute For Artificial Intelligence , University Of Washington Medical Center , Madrona Venture Group , Washington Medical , Allen Institute , Artificial Intelligence , Fred Hutchinson Cancer Research Institute , New York Company , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Motion Sensors , Healthcare It , Foodborne Pathogens , Diagnostics Company ,